Literature DB >> 2679956

Cardiac electrophysiological actions of captopril: lack of direct antiarrhythmic effects.

P D Hemsworth1, R T Pallandi, T J Campbell.   

Abstract

1. Standard microelectrode techniques were used to study the effects of captopril (1, 10 and 100 microM) on action potentials recorded from guinea-pig ventricular cells and sinoatrial node cells. 2. Captopril had no effect on the maximum rate of depolarization (Vmax) of ventricular action potentials in cells exposed to either normal Locke solution or 'simulated ischaemic' solution (K1 11.2 mM; pH-6.4; PO2 less than 80 mmHg), nor was there any augmentation of the normal small decline in Vmax with increasing stimulation rate (range of interstimulus intervals = 2400 ms to 300 ms). 3. Captopril had no effect on the duration of ventricular action potentials, nor did it alter the shortening seen on exposure to simulated ischaemia. 4. Captopril did not alter spontaneous sinus cycle length or any recorded parameter of sinus node action potentials. 5. It is concluded that any antiarrhythmic effects observed during clinical use of captopril are most unlikely to be due to direct actions of the drug on cardiac cell membrane properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679956      PMCID: PMC1854648          DOI: 10.1111/j.1476-5381.1989.tb16881.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

Review 1.  A classification of antiarrhythmic actions reassessed after a decade of new drugs.

Authors:  E M Vaughan Williams
Journal:  J Clin Pharmacol       Date:  1984-04       Impact factor: 3.126

Review 2.  Angiotensin-converting enzyme inhibitors: past, present, and bright future.

Authors:  C R Edwards; P L Padfield
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

3.  The use of captopril in the management of cardiac failure.

Authors:  J G Cleland; H J Dargie; J I Robertson; S G Ball; G P Hodsman
Journal:  Scott Med J       Date:  1984-04       Impact factor: 0.729

4.  Effect of food on the bioavailability of captopril in healthy subjects.

Authors:  S M Singhvi; D N McKinstry; J M Shaw; D A Willard; B H Migdalof
Journal:  J Clin Pharmacol       Date:  1982 Feb-Mar       Impact factor: 3.126

5.  Disposition of captopril in normal subjects.

Authors:  K J Kripalani; D N McKinstry; S M Singhvi; D A Willard; R A Vukovich; B H Migdalof
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

6.  Captopril in heart failure. A double blind controlled trial.

Authors:  J G Cleland; H J Dargie; G P Hodsman; S G Ball; J I Robertson; J J Morton; B W East; I Robertson; G D Murray; G Gillen
Journal:  Br Heart J       Date:  1984-11

7.  Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion.

Authors:  W H Van Gilst; P A De Graeff; J H Kingma; H Wesseling; C D De Langen
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

Review 8.  Circulating versus local renin-angiotensin system in cardiovascular homeostasis.

Authors:  V J Dzau
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

9.  Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.

Authors:  T J Campbell
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

10.  Computer recognition of cardiac arrhythmias and statistical approaches to arrhythmia analysis.

Authors:  J Morganroth
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

View more
  2 in total

1.  Effect of captopril on membrane currents of ventricular myocytes.

Authors:  Y G Wang; Z Y Lu
Journal:  J Tongji Med Univ       Date:  1995

2.  Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial.

Authors:  A Pipilis; M Flather; R Collins; A Hargreaves; T Kolettis; N Boon; C Foster; P Appleby; P Sleight
Journal:  Br Heart J       Date:  1993-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.